Paper41627331
Recent developments in CRISPR/Cas9 genome editing research for edible fungiculture.
Roy N and 3 others. Funct Integr Genomics, 2026. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Recent developments in CRISPR/Cas9 genome editing research for edible fungiculture. Papers, record 41627331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41627331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CRISPR-Cas Systems | Major topic |
| Gene Editing | Major topic |
| Agaricales | Major topic |
| Genome, Fungal | Major topic |
Source PubMed
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29476632 | Biosynthesis of a ganoderic acid in Saccharomyces cerevisiae by expressing a cytochrome P450 gene from Ganoderma lucidum. | Biotechnol Bioeng | 2018 | https://conductscience.org/library/papers/29476632 | PubMed |
| 2 | 28455526 | Genome editing in the mushroom-forming basidiomycete Coprinopsis cinerea, optimized by a high-throughput transformation system. | Sci Rep | 2017 | https://conductscience.org/library/papers/28455526 | PubMed |
| 3 | 39590667 | Unlocking Fungal Potential: The CRISPR-Cas System as a Strategy for Secondary Metabolite Discovery. | J Fungi (Basel) | 2024 | https://conductscience.org/library/papers/39590667 | PubMed |
| 4 | 37404005 | Application of CRISPR in Filamentous Fungi and Macrofungi: From Component Function to Development Potentiality. | ACS Synth Biol | 2023 | https://conductscience.org/library/papers/37404005 | PubMed |
| 5 | 40055491 | CRISPR-Cas applications in agriculture and plant research. | Nat Rev Mol Cell Biol | 2025 | https://conductscience.org/library/papers/40055491 | PubMed |
| 6 | 36071963 | Genome editing in the edible fungus Poria cocos using CRISPR-Cas9 system integrating genome-wide off-target prediction and detection. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36071963 | PubMed |
| 7 | 39085047 | The rise and future of CRISPR-based approaches for high-throughput genomics. | FEMS Microbiol Rev | 2024 | https://conductscience.org/library/papers/39085047 | PubMed |
| 8 | 36001999 | Gene targeting of dikaryotic Pleurotus ostreatus nuclei using the CRISPR/Cas9 system. | FEMS Microbiol Lett | 2022 | https://conductscience.org/library/papers/36001999 | PubMed |
| 9 | 29399381 | Anticancer Activity of Ganoderic Acid DM: Current Status and Future Perspective. | J Clin Cell Immunol | 2017 | https://conductscience.org/library/papers/29399381 | PubMed |
| 10 | 32841542 | Efficient genome editing in filamentous fungi via an improved CRISPR-Cas9 ribonucleoprotein method facilitated by chemical reagents. | Microb Biotechnol | 2021 | https://conductscience.org/library/papers/32841542 | PubMed |
| 11 | 38521182 | Food and human health applications of edible mushroom by-products. | N Biotechnol | 2024 | https://conductscience.org/library/papers/38521182 | PubMed |
| 12 | 36307231 | Harnessing synthetic biology for mushroom farming. | Trends Biotechnol | 2023 | https://conductscience.org/library/papers/36307231 | PubMed |
| 13 | 37746125 | Fungal biotechnology: From yesterday to tomorrow. | Front Fungal Biol | 2023 | https://conductscience.org/library/papers/37746125 | PubMed |
| 14 | 34153439 | Functional analyses of Pleurotus ostreatus pcc1 and clp1 using CRISPR/Cas9. | Fungal Genet Biol | 2021 | https://conductscience.org/library/papers/34153439 | PubMed |
| 15 | 31321701 | The EU regulatory framework on genetically modified organisms (GMOs). | Transgenic Res | 2019 | https://conductscience.org/library/papers/31321701 | PubMed |
| 16 | 29946301 | Efficient CRISPR-Cas9 Gene Disruption System in Edible-Medicinal Mushroom Cordyceps militaris. | Front Microbiol | 2018 | https://conductscience.org/library/papers/29946301 | PubMed |
| 17 | 37429890 | The Cas9-gRNA ribonucleoprotein complex-mediated editing of pyrG in Ganoderma lucidum and unexpected insertion of contaminated DNA fragments. | Sci Rep | 2023 | https://conductscience.org/library/papers/37429890 | PubMed |
| 18 | 34954815 | Applications of CRISPR/Cas gene-editing technology in yeast and fungi. | Arch Microbiol | 2021 | https://conductscience.org/library/papers/34954815 | PubMed |
| 19 | 38786666 | Current Advances in the Functional Genes of Edible and Medicinal Fungi: Research Techniques, Functional Analysis, and Prospects. | J Fungi (Basel) | 2024 | https://conductscience.org/library/papers/38786666 | PubMed |
| 20 | 37173280 | Development of a gene-targeting system using CRISPR/Cas9 and utilization of pyrG as a novel selectable marker in Lentinula edodes. | FEMS Microbiol Lett | 2023 | https://conductscience.org/library/papers/37173280 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42201594 | Translational stem cell therapy for neurodegeneration and CNS trauma: a focused review. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42201594 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41627331
GET https://conductscience.org/api/papers/v1/41627331/references?page=2